» Authors » Shiyang Pan

Shiyang Pan

Explore the profile of Shiyang Pan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 86
Citations 1512
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang Q, Cai X, Li Y, Zhao J, Liu Z, Jiang Y, et al.
Front Microbiol . 2022 Oct; 13:1006375. PMID: 36274705
To have a comprehensive understanding of epidemiology and antifungal susceptibilities in pathogenic yeasts, the China Antifungal Resistance Surveillance Trial (CARST-fungi) study was conducted. All yeast isolates were identified by ribosomal...
12.
Ruan H, Wang Z, Sun Z, Wei J, Zhang L, Ju H, et al.
Clin Transl Med . 2022 Jun; 12(6):e885. PMID: 35678121
Leptomeningeal metastases (LM) occur in patients with breast cancer (BC) and lung cancer (LC) showing exceptionally poor prognosis. The cerebrospinal fluid (CSF) tumour microenvironment (TME) of LM patients is not...
13.
Salinas A, Ashavaid T, Payne D, Linder M, Baluchova K, Pan S, et al.
Clin Chim Acta . 2022 Apr; 531:237-242. PMID: 35413298
Background: In the current COVID-19 pandemic, early and rapid diagnosis of potentially infected and contagious individuals enables containment of the disease through quarantine and contact tracing. The rapid global expansion...
14.
Xu J, Sun Z, Ju H, Xie E, Mu Y, Xu J, et al.
Int J Gen Med . 2022 Mar; 15:2549-2573. PMID: 35282643
Purpose: Mucinous adenocarcinoma (MA) and signet ring cell carcinoma (SRCC) are aggressive colorectal cancer histological subtypes with dismal prognosis. This study investigated prognostic factors and constructed novel nomograms for MA...
15.
Xu J, Chen W, Sun Z, Peng H, Zhou C, Pan S
Dis Markers . 2022 Mar; 2022:5470166. PMID: 35251373
Background: Cell-free DNA (cfDNA) has attracted considerable attention in precision medicine. However, few data are available regarding to the prognostic value of cfDNA variables in CA15-3 normal breast cancer (BC)...
16.
Xie E, Lin M, Sun Z, Jin Y, Zhang S, Huang L, et al.
Transl Cancer Res . 2022 Feb; 10(7):3458-3469. PMID: 35116650
Background: Lung cancer has a high incidence and a 5-year survival rate of less than 15%. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases. Chemotherapy...
17.
Ren Z, Ding H, Cai Z, Mu Y, Wang L, Pan S
Medicine (Baltimore) . 2021 Dec; 100(51):e28110. PMID: 34941053
This study is to develop and validate a preoperative prediction model for malignancy of solitary pulmonary nodules. Data from 409 patients who underwent solitary pulmonary nodule resection at the First...
18.
Liu Z, Tong Y, Wu J, Du L, Wei C, Cui W, et al.
Ann Transl Med . 2021 Jan; 8(24):1631. PMID: 33490143
The coronavirus disease 2019 (COVID-19) has already become a pandemic wherein the infection's timely diagnosis has proven beneficial to patient treatment and disease control. Nucleic acid detection has been the...
19.
Gu C, Luo Y, Zhang S, Xu J, Zhang J, Ju H, et al.
Thorac Cancer . 2020 Aug; 11(9):2630-2638. PMID: 32744429
Background: Previously, we developed a monoclonal antibody (mAb) NJ001 that binds to the antigen SP70 in human non-small cell lung cancer (NSCLC) cells and showed it could inhibit lung adenocarcinoma...
20.
Jing R, Cui M, Ju S, Pan S
Clin Lab . 2020 Apr; 66(4). PMID: 32255307
Background: Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 are the most commonly used tumor markers in gastric cancer (GC). The purpose of this study was to dynamically monitor the...